Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.9%

6 terminated/withdrawn out of 55 trials

Success Rate

81.3%

-5.3% vs industry average

Late-Stage Pipeline

25%

14 trials in Phase 3/4

Results Transparency

8%

2 of 26 completed trials have results

Key Signals

6 recruiting2 with results6 terminated

Enrollment Performance

Analytics

N/A
28(62.2%)
Phase 3
8(17.8%)
Phase 4
6(13.3%)
Phase 2
2(4.4%)
Phase 1
1(2.2%)
45Total
N/A(28)
Phase 3(8)
Phase 4(6)
Phase 2(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (55)

Showing 20 of 55 trials
NCT07233837Not ApplicableRecruiting

Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units

Role: collaborator

NCT07093450Not ApplicableRecruiting

Quality Improvement Intervention for a Safe Antimicrobial Use Reduction in Critically Ill Patients

Role: lead

NCT05673226Not ApplicableCompleted

Organosilane for Surface Cleaning in Intensive Care Units

Role: collaborator

NCT07089134Not ApplicableNot Yet Recruiting

Virtual Reality in Intensive Care Unit: Patient Satisfaction, Clinical and Functional Outcomes, Feasibility

Role: lead

NCT06681376Not ApplicableNot Yet Recruiting

Enhancing the Emergency Department Experience for Older Adults: Study Protocol for the Implementation of a Comfort Menu and Cart

Role: lead

NCT01888198Active Not Recruiting

Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment

Role: collaborator

NCT05266066Not ApplicableRecruiting

Ventilator-associated Tracheobronchitis Initiative to Conduct Antibiotic Evaluation

Role: lead

NCT05950269Not ApplicableCompleted

Walking Aid and Locomotion Knowledge in Emergency Rooms (WALKER 1) for Elderly People

Role: lead

NCT06339632Not ApplicableRecruiting

Effects of Transcutaneous Electrical Phrenic Nerve Stimulation and Transcutaneous Electrical Diaphragmatic Stimulation

Role: lead

NCT06402851Phase 4Recruiting

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

Role: lead

NCT03754257Not ApplicableCompleted

Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock

Role: lead

NCT02647385Not ApplicableActive Not Recruiting

Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation

Role: lead

NCT03452878Active Not Recruiting

Evaluation of the Functional Results of Bilateral Amygdalotomy for Refractory Aggressive Patients

Role: lead

NCT04939883Phase 4Unknown

Effects of Carvedilol on Cardiotoxicity in Cancer Patients Submitted to Anthracycline Therapy

Role: lead

NCT06479031Not ApplicableNot Yet Recruiting

Occupational Therapy Intervention on the Prevention of Delirium and Occupational Performance Status in Elderly Patients

Role: lead

NCT05840458Unknown

Pericapsular Nerve Block in Proximal Femoral Fractures

Role: lead

NCT03189420Active Not Recruiting

Glioma Microenvironment an Exploratory Study

Role: lead

NCT04945213Phase 3Recruiting

Biperiden Trial for Epilepsy Prevention

Role: lead

NCT05192213Phase 3Terminated

Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock

Role: lead

NCT06173297Completed

Assessing the Agreement Between Endoscopic and Histopathological Diagnosis of Colorectal Sessile Serrated Lesions.

Role: lead